We Help Companies Find New Sales Opportunities
BioProgress is to acquire Melbrosin, the supplier of natural health products with 52 staff in Germany, Italy, Austria and the UK, for up to £24m.
BioProgress has acquired PharmaHerb, the vitamin and nutritional products supplier, for £0.6m.
BioProgress has acquired DMPL, the French pharmaceuticals marketing company, for £0.3m.
BioProgress is to acquire the US pharmaceutical trading assets of AirPharma for £4.2m, including 20 brands.
BioProgress is to acquire Segix Farma, the Italian pharmaceuticals company that specialises in the anti-infective, gastrointestinal and oncology sectors, for up to £1.3m.
BioProgress is to relocate its Cambridgeshire-based pharmaceuticals business and 15 staff from the town of March to the Cambridge Science Park in February.
BioProgress is to acquire Dexo, the French pharmaceuticals company, for £8m, and has also announced the formation of a generic medicines joint venture with Crescent Pharma.
BioProgress has acquired Aquafilm, the US developer of pill coating products, for £6m, and has also raised £10m in a share placing.
BioProgress is looking to raise £6.6m for the development of a pharmaceutical production plant in Cambridgeshire, having won a contract to supply FMC of the US.